We're updating this page to be current soon.



Vanderlugt, C. L. and S. D. Miller.  2002. 
Role of epitope spreading in immune-mediated diseases:  Implications for immunotherapy. 
Nature Rev. Immunol.  2:85-95.

Howard, L. M., S. Ostrovidov, C. E. Smith, M. C. Dal Canto, and S. D. Miller.  2002. 
Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis. 
J. Clin. Invest.  109:233-241.

Rasley, A., K. L. Bost, J. K. Olson, S. D. Miller, and I. Marriott.  2002. 
Expression of functional NK-1 receptors in murine microglia. 
Glia 37:258-267.

Neville, K. L., J. Padilla, L. A. Matis, and S. D. Miller.  2002. 
Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease:  Implications for the treatment of MS. 
J. Neuroimmunol.  123:18-29.

Eagar, T. N., N. J. Karandikar, J. A. Bluestone, and S. D. Miller.  2002. 
The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. 
Eur. J. Immunol.  32:972-981.

Girvin, A. M., M. C. Dal Canto, and S. D. Miller.  2002. 
CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated costimulation. 
J. Autoimmunity.  16:83-94.

Tompkins, S. M., J. Padilla, M. C. Dal Canto, J. P.-Y. Ting, L. Van Kaer, and S. D. Miller.  2002. 
De novo CNS processing of myelin antigen is required for the initiation of EAE. 
J. Immunol.  168:4173-4183.

Tompkins, S. M. and S. D. Miller.  2002. 
An array of possibilities for multiple sclerosis. 
Nature Med.  8:451-453.

Girvin, A. M., K. B. Gordon, C. J. Welsh, and S. D. Miller.  2002. 
Differential abilities of central nervous system-resident endothelial cells and astrocytes to serve as inducible antigen presenting cells. 
Blood.  99:3692-3701.

Tompkins, S. M., K. G. Fuller, and S. D. Miller.  2002. 
Theilerís virus-mediated autoimmunity: Local presentation of CNS antigens and epitope spreading. 
Ann. N.Y. Acad. Sci.  958:26-38.

Olson, J. K., T. N. Eagar, and S. D. Miller.  2002. 
Functional activation of myelin-specific T cells by virus-induced molecular mimicry. 
J. Immunol.  169:2719-2726.

Howard, L. M., M. C. Dal Canto, and S. D. Miller.  2002. 
Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses. 
J. Neuroimmunol.  129:58-65.

Kohm, A. P., P. A. Carpentier, H. A. Anger, and S. D. Miller.  2002. 
Cutting Edge:  CD4+CD25+ T regulatory cells suppress antigen-specific autoreactive immune responses and CNS inflammation during active experimental autoimmune encephalomyelitis. 
J. Immunol.  169:4712-4716.

Xu L, Robinson N, Miller SD, Chan LS.
Characterization of BALB/c mice B lymphocyte autoimmune responses to skin basement membrane component type XVII collagen, the target antigen of autoimmune skin disease bullous pemphigoid.

Miller, S. D., Y. Katz-Levy, and K. L. Neville, and C. L. Vanderlugt.  2001. 
Virus-induced autoimmunity:  Epitope spreading to myelin autoepitopes in Theilerís virus infection of the CNS. 
Adv. Virus Res.  56:199-217.

Olson, J. K., J. L. Croxford, M. A. Calenoff, M. C. Dal Canto, and S. D. Miller.  2001. 
A virus-induced molecular mimicry model of multiple sclerosis. 
J. Clin. Invest.  108:311-318.

Palma, J. P., H. G. Lee, M. Mohindru, B. S. Kang, M. C. Dal Canto, S. D. Miller, and B. S. Kim.  2001. 
Enhanced susceptibility to Theilerís virus-induced demyelinating disease in perforin-deficient mice. 
J. Neuroimmunol.  116:125-135.

Miller, S. D. and T. N. Eagar.  2001. 
Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases. 
Adv. Exp. Med. Biol. 490:99-107.

Salomon, B., L. Rhee, H. Bour-Jordan, H. Hsin, A. Montag, B. Soliven, J. Arcella, A. M. Girvin, J. Padilla, S. D. Miller, and J. A. Bluestone.  2001. 
Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. 
J. Exp. Med.  194:677-684.

Eagar, T. N. , S. M. Tompkins, and S. D. Miller.  2001. 
Helper T cell subsets and control of the inflammatory response. 
In:  Clinical Immunology, 2nd Ed. (R. R. Rich, T. A. Fleisher, W. T. Shearer, B. L. Kotzin and H. W. Schroder, Jr., eds.).  Mosby Publishers, London.  pp. 16.1-16.12.

Olson, J. K., J. L. Croxford, and S. D. Miller.  2001. 
Virus-induced autoimmunity:  Potential role of viruses in initiation and progression of T cell-mediated autoimmune disease. 
Viral Immunol.  14:227-250.

Begolka, W. S., L. M. Haynes, J. K. Olson, J. Padilla, K. L. Neville, M. C. Dal Canto, J. P. Palma, B. S. Kim, and S. D. Miller.  2001. 
CD8-deficient SJL mice display enhanced susceptibility to Theilerís virus infection and increased demyelinating pathology. 
J. Neurovirol.  7:1-12.

Olson, J. K., A. M. Girvin, and S. D. Miller.  2001. 
Direct activation of innate and antigen presenting functions of microglia following infection with Theilerís virus. 
J. Virol.  75:9780-9789.

Wang, K., A. E. Busker-Mannie, J. Hoeft, K. Vasquez, S. D. Miller, R. W. Melvold, and C. Waltenbaugh.  2001. 
Prolonged Hya-disparate skin graft survival in ethanol-consuming mice correlation with impaired delayed hypersensitivity. 
Alcoholism Clin. Exp. Res.  25:1542-1548.

Miller SD, Olson JK, Croxford JL.
Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from theiler's virus infection.
J Autoimmun. 2001 May;16(3):219-27.

Theien BE, Vanderlugt CL, Eagar TN, Nickerson-Nutter C, Nazareno R, Kuchroo VK, Miller SD.
Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.
J Clin Invest. 2001 Apr;107(8):995-1006.

Godsel LM, Wang K, Schodin BA, Leon JS, Miller SD, Engman DM.
Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance.
Circulation. 2001 Mar 27;103(12):1709-14.

Howard LM, Miller SD.
Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ.
J Immunol. 2001 Feb 1;166(3):1547-53.

Suvannavejh GC, Lee HO, Padilla J, Dal Canto MC, Barrett TA, Miller SD.
Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis.
Cell Immunol. 2000 Oct 10;205(1):24-33.

Sabelko-Downes KA, Gimenez MT, Suvannavejh GC, Miller SD, Russell JH.
Genetic control of pathogenic mechanisms in autoimmune demyelinating disease.
J Neuroimmunol. 2000 Oct 2;110(1-2):168-76.

Katz-Levy Y, Neville KL, Padilla J, Rahbe S, Begolka WS, Girvin AM, Olson JK, Vanderlugt CL, Miller SD.
Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice.
J Immunol. 2000 Nov 1;165(9):5304-14.

Karandikar NJ, Eagar TN, Vanderlugt CL, Bluestone JA, Miller SD.
CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2000 Sep 22;109(2):173-80.

Neville KL, Dal Canto MC, Bluestone JA, Miller SD.
CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.
J Virol. 2000 Sep;74(18):8349-57.

Lee HO, Miller SD, Hurst SD, Tan LJ, Cooper CJ, Barrett TA.
Interferon gamma induction during oral tolerance reduces T-cell migration to sites of inflammation.
Gastroenterology. 2000 Jul;119(1):129-38.

Haynes LM, Vanderlugt CL, Dal Canto MC, Melvold RW, Miller SD.
CD8(+) T cells from Theiler's virus-resistant BALB/cByJ mice downregulate pathogenic virus-specific CD4(+) T cells.
J Neuroimmunol. 2000 Jul 1;106(1-2):43-52.

Vanderlugt CL, Rahbe SM, Elliott PJ, Dal Canto MC, Miller SD.
Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519.
J Autoimmun. 2000 May;14(3):205-11.

Dal Canto MC, Calenoff MA, Miller SD, Vanderlugt CL.
Lymphocytes from mice chronically infected with Theiler's murine encephalomyelitis virus produce demyelination of organotypic cultures after stimulation with the major encephalitogenic epitope of myelin proteolipid protein. Epitope spreading in TMEV infection has functional activity.
J Neuroimmunol. 2000 Apr 3;104(1):79-84.

Suvannavejh GC, Dal Canto MC, Matis LA, Miller SD.
Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis.
J Clin Invest. 2000 Jan;105(2):223-31.

Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD.
Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
J Immunol. 2000 Jan 15;164(2):670-8.

Girvin AM, Dal Canto MC, Rhee L, Salomon B, Sharpe A, Bluestone JA, Miller SD.
A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
J Immunol. 2000 Jan 1;164(1):136-43.

Hoffman LM, Fife BT, Begolka WS, Miller SD, Karpus WJ.
Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease.
J Neurovirol. 1999 Dec;5(6):635-42.

Burt RK, Padilla J, Dal Canto MC, Miller SD.
Viral hyperinfection of the central nervous system and high mortality after hematopoietic stem cell transplantation for treatment of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Blood. 1999 Oct 15;94(8):2915-22.

Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, Miller SD.
Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
J Clin Invest. 1999 Sep;104(5):599-610.

Nicholson SM, Haynes LM, Vanderlugt CL, Miller SD, Melvold RW.
The role of protective CD8+ T cells in resistance of BALB/c mice to Theiler's murine encephalomyelitis virus-induced demyelinating disease: regulatory vs. lytic.
J Neuroimmunol. 1999 Aug 3;98(2):136-46.

Marten NW, Stohlman SA, Smith-Begolka W, Miller SD, Dimacali E, Yao Q, Stohl S, Goverman J, Bergmann CC.
Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system.
J Immunol. 1999 Apr 1;162(7):3905-14

Begolka WS, Miller SD.
Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encehalomyelitis.
Res Immunol. 1998 Nov-Dec;149(9):771-81; discussion 843-4, 855-60. Review.

Howard LM, Miga AJ, Vanderlugt CL, Dal Canto MC, Laman JD, Noelle RJ, Miller SD.
Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.
J Clin Invest. 1999 Jan;103(2):281-90.

Vanderlugt CL, Begolka WS, Neville KL, Katz-Levy Y, Howard LM, Eagar TN, Bluestone JA, Miller SD.
The functional significance of epitope spreading and its regulation by co-stimulatory molecules.
Immunol Rev. 1998 Aug;164:63-72. Review.

Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD.
Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
J Immunol. 1998 Oct 15;161(8):4437-46.

Pope JG, Vanderlugt CL, Rahbe SM, Lipton HL, Miller SD.
Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus.
J Virol. 1998 Oct;72(10):7762-71.

Birnbaum G, Kotilinek L, Miller SD, Raine CS, Gao YL, Lehmann PV, Gupta RS. Related Articles
Heat shock proteins and experimental autoimmune encephalomyelitis. II: environmental infection and extra-neuraxial inflammation alter the course of chronic relapsing encephalomyelitis.
J Neuroimmunol. 1998 Oct 1;90(2):149-61.

Karandikar NJ, Vanderlugt CL, Bluestone JA, Miller SD.
Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease.
J Neuroimmunol. 1998 Aug 14;89(1-2):10-8. Review.

Karandikar NJ, Vanderlugt CL, Eagar T, Tan L, Bluestone JA, Miller SD.
Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis.
J Immunol. 1998 Jul 1;161(1):192-9.

Tan L, Gordon KB, Mueller JP, Matis LA, Miller SD.
Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
J Immunol. 1998 May 1;160(9):4271-9.

Burt RK, Padilla J, Begolka WS, Canto MC, Miller SD.
Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis.
Blood. 1998 Apr 1;91(7):2609-16.

Tan LJ, Vanderlugt CL, McRae BL, Miller SD.
Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for anergy/deletion.
Autoimmunity. 1998;27(1):13-28.

Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, Wojnarowska F, Stevens SR, Chen M, Fairley JA, Woodley DT, Miller SD, Gordon KB.
Epitope spreading: lessons from autoimmune skin diseases.
J Invest Dermatol. 1998 Feb;110(2):103-9. Review.

Burt RK, Burns WH, Miller SD.
Bone marrow transplantation for multiple sclerosis: returning to Pandora's box.
Immunol Today. 1997 Dec;18(12):559-61.

Vanderlugt CL, Karandikar NJ, Lenschow DJ, Dal Canto MC, Bluestone JA, Miller SD.
Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE.
J Neuroimmunol. 1997 Nov;79(2):113-8.

Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS.
Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading.
Nat Med. 1997 Oct;3(10):1133-6.

Kennedy KJ, Smith WS, Miller SD, Karpus WJ.
Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance.
J Immunol. 1997 Jul 15;159(2):1036-44.

Miller SD, Vanderlugt CL, Begolka WS, Pao W, Neville KL, Yauch RL, Kim BS.
Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus.
J Neurovirol. 1997 May;3 Suppl 1:S62-5.

McRae BL, Karandikar NJ, Miller SD.
Degenerate antigen recognition by CD4+ effector T cells in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 1997 May;75(1-2):156-62.

Nikcevich KM, Gordon KB, Tan L, Hurst SD, Kroepfl JF, Gardinier M, Barrett TA, Miller SD.
IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells.
J Immunol. 1997 Jan 15;158(2):614-21.

Vanderlugt CJ, Miller SD.
Epitope spreading.
Curr Opin Immunol. 1996 Dec;8(6):831-6. Review.

Dal Canto MC, Kim BS, Miller SD, Melvold RW.
Theiler's Murine Encephalomyelitis Virus (TMEV)-Induced Demyelination: A Model for Human Multiple Sclerosis
Methods. 1996 Dec;10(3):453-61.

Clark L, Fareed M, Miller SD, Merryman C, Heber-Katz E.
Corneal infection with herpes simplex virus type 1 leads to autoimmune responses in rats.
J Neurosci Res. 1996 Sep 15;45(6):770-5.

Karpus WJ, Kennedy KJ, Smith WS, Miller SD.
Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.
J Neurosci Res. 1996 Aug 15;45(4):410-23.

Vandenbark AA, Vainiene M, Ariail K, Miller SD, Offner H.
Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.
J Neurosci Res. 1996 Aug 15;45(4):430-8.

Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA.
CTLA-4: a negative regulator of autoimmune disease.
J Exp Med. 1996 Aug 1;184(2):783-8.

Pope JG, Karpus WJ, VanderLugt C, Miller SD.
Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology.
J Immunol. 1996 May 15;156(10):4050-8.

Nicholson SM, Dal Canto MC, Miller SD, Melvold RW.
Adoptively transferred CD8+ T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice.
J Immunol. 1996 Feb 1;156(3):1276-83.

Miller SD, Vanderlugt CL, Lenschow DJ, Pope JG, Karandikar NJ, Dal Canto MC, Bluestone JA.
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE.
Immunity. 1995 Dec;3(6):739-45.

Vandenbark AA, Celnik B, Vainiene M, Miller SD, Offner H.
Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism.
J Immunol. 1995 Dec 15;155(12):5861-7

Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD.
An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
J Immunol. 1995 Nov 15;155(10):5003-10.

Khoruts A, Miller SD, Jenkins MK.
Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells.
J Immunol. 1995 Nov 15;155(10):5011-7.

Pullen LC, Park SH, Miller SD, Dal Canto MC, Kim BS.
Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease.
J Immunol. 1995 Nov 1;155(9):4497-503.

Dal Canto MC, Melvold RW, Kim BS, Miller SD.
Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.
Microsc Res Tech. 1995 Oct 15;32(3):215-29. Review.

Karpus WJ, Pope JG, Peterson JD, Dal Canto MC, Miller SD.
Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction.
J Immunol. 1995 Jul 15;155(2):947-57.

McRae BL, Nikcevich KM, Karpus WJ, Hurst SD, Miller SD.
Differential recognition of peptide analogs by naive verses activated PLP 139-151-specific CD4+ T cells.
J Neuroimmunol. 1995 Jul;60(1-2):17-28.

McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD.
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
J Exp Med. 1995 Jul 1;182(1):75-85.

Lipton HL, Melvold R, Miller SD, Dal Canto MC.
Mutation of a major histocompatibility class I locus, H-2D, leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease.
J Neurovirol. 1995 Jun;1(2):138-44.

Miller SD, McRae BL, Vanderlugt CL, Nikcevich KM, Pope JG, Pope L, Karpus WJ.
Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases.
Immunol Rev. 1995 Apr;144:225-44. Review.

Offner H, Malotky MK, Pope L, Vainiene M, Celnik B, Miller SD, Vandenbark AA.
Increased severity of experimental autoimmune encephalomyelitis in rats tolerized as adults but not neonatally to a protective TCR V beta 8 CDR2 idiotope.
J Immunol. 1995 Jan 15;154(2):928-35

Pullen LC, Miller SD, Dal Canto MC, Van der Meide PH, Kim BS.
Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease.
J Neuroimmunol. 1994 Dec;55(2):143-52.

Miller SD, Karpus WJ.
The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases.
Immunol Today. 1994 Aug;15(8):356-61. Review.

McRae BL, Miller SD.
Fine specificity of CD4+ T cell responses to the dominant encephalitogenic PLP 139-151 peptide in SJL/J mice.
Neurochem Res. 1994 Aug;19(8):997-1004.

Malotky MK, Pope L, Miller SD.
Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats.
J Immunol. 1994 Jul 15;153(2):841-51.

Nicholson SM, Peterson JD, Miller SD, Wang K, Dal Canto MC, Melvold RW.
BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.
J Neuroimmunol. 1994 Jun;52(1):19-24.

Tibbetts RS, Kim IY, Olson CL, Barthel LM, Sullivan MA, Winquist AG, Miller SD, Engman DM.
Molecular cloning and characterization of the 78-kilodalton glucose-regulated protein of Trypanosoma cruzi.
Infect Immun. 1994 Jun;62(6):2499-507.

Karpus WJ, Peterson JD, Miller SD.
Anergy in vivo: down-regulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses.
Int Immunol. 1994 May;6(5):721-30.

Malotky MK, Paterson PY, Miller SD.
Differential recognition of sequences within the encephalitogenic region of myelin basic protein capable of eliciting cell-mediated immune responses in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 1994 Apr;51(1):109.

Tibbetts RS, McCormick TS, Rowland EC, Miller SD, Engman DM.
Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice.
J Immunol. 1994 Feb 1;152(3):1493-9.

Gerety SJ, Karpus WJ, Cubbon AR, Goswami RG, Rundell MK, Peterson JD, Miller SD.
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
J Immunol. 1994 Jan 15;152(2):908-18.

Gerety SJ, Rundell MK, Dal Canto MC, Miller SD.
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
J Immunol. 1994 Jan 15;152(2):919-29.

Malotky MK, Paterson PY, Miller SD.
Differential recognition of sequences within the encephalitogenic region of myelin basic protein capable of eliciting cell-mediated immune responses in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 1993 Nov-Dec;48(2):135-42.

Pullen LC, Miller SD, Dal Canto MC, Kim BS.
Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination.
Eur J Immunol. 1993 Sep;23(9):2287-93.

Peterson JD, Karpus WJ, Clatch RJ, Miller SD.
Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus.
Eur J Immunol. 1993 Jan;23(1):46-55.

McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD.
Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.
J Neuroimmunol. 1992 Jun;38(3):229-40.

Tan LJ, Kennedy MK, Miller SD.
Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
J Immunol. 1992 May 1;148(9):2748-55.

Pope L, Paterson PY, Miller SD.
Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats.
J Neuroimmunol. 1992 Apr;37(3):177-89.

Peterson JD, Waltenbaugh C, Miller SD.
IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains.
Immunology. 1992 Apr;75(4):652-8.

Miller SD, Tan LJ, Pope L, McRae BL, Karpus WJ.
Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis.
Int Rev Immunol. 1992;9(3):203-22. Review.

Miller SD, Tan LJ, Kennedy MK, Dal Canto MC.
Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction.
Ann N Y Acad Sci. 1991 Dec 30;636:79-94.

Tan LJ, Kennedy MK, Dal Canto MC, Miller SD.
Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance.
J Immunol. 1991 Sep 15;147(6):1797-802.

Lipton HL, Calenoff M, Bandyopadhyay P, Miller SD, Dal Canto MC, Gerety S, Jensen K. Related Articles
The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence.
J Virol. 1991 Aug;65(8):4370-7.

Da Canto MC, Kennedy MK, Tan LJ, Miller SD.
Immune regulation by tolerization in EAE and in Theiler's murine encephalomyelitis virus (TMEV) infection (1).
Acta Neurol (Napoli). 1991 Apr;13(2):107-112. Review.

Gerety SJ, Clatch RJ, Lipton HL, Goswami RG, Rundell MK, Miller SD.
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice.
J Immunol. 1991 Apr 1;146(7):2401-8.

Kennedy MK, Tan LJ, Dal Canto MC, Miller SD.
Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction.
J Immunol. 1990 Jul 1;145(1):117-26.

Clatch RJ, Miller SD, Metzner R, Dal Canto MC, Lipton HL.
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV).
Virology. 1990 May;176(1):244-54.

Melvold RW, Jokinen DM, Miller SD, Dal Canto MC, Lipton HL.
Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.
J Virol. 1990 Feb;64(2):686-90.

Peterson JD, Miller SD, Waltenbaugh C.
Rapid biotin-avidin method for quantitation of antiviral antibody isotypes.
J Virol Methods. 1990 Feb;27(2):189-201.

Kennedy MK, Tan LJ, Dal Canto MC, Tuohy VK, Lu ZJ, Trotter JL, Miller SD.
Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
J Immunol. 1990 Feb 1;144(3):909-15.

Busker AE, Miller SD, Melvold RW.
Induction of allograft tolerance to the H-Y antigen in adult C57BL/6 mice: differential effects on delayed-type hypersensitivity and cytolytic T-lymphocyte activity.
Cell Immunol. 1990 Jan;125(1):225-34.

Miller SD, Gerety SJ, Kennedy MK, Peterson JD, Trotter JL, Tuohy VK, Waltenbaugh C, Dal Canto MC, Lipton HL.
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.
J Neuroimmunol. 1990 Jan;26(1):9-23.

Peterson JD, Kim JY, Melvold RW, Miller SD, Waltenbaugh C.
A rapid method for quantitation of antiviral antibodies.
J Immunol Methods. 1989 Apr 21;119(1):83-94.

Kennedy MK, Dal Canto MC, Trotter JL, Miller SD.
Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice.
J Immunol. 1988 Nov 1;141(9):2986-93.

Miller SD, Clatch RJ, Lipton HL.
Fine specificity of T-cell-mediated immune responses of susceptible and resistant strains in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Ann N Y Acad Sci. 1988;540:674-7.

Clatch RJ, Pevear DC, Rozhon E, Roos RP, Miller SD, Lipton HL.
Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins.
J Gen Virol. 1987 Dec;68 ( Pt 12):3191-6.

Clatch RJ, Lipton HL, Miller SD.
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains.
Microb Pathog. 1987 Nov;3(5):327-37.

Kennedy MK, Clatch RJ, Dal Canto MC, Trotter JL, Miller SD.
Monoclonal antibody-induced inhibition of relapsing EAE in SJL/J mice correlates with inhibition of neuroantigen-specific cell-mediated immune responses.
J Neuroimmunol. 1987 Nov;16(3):345-64. Review.

Jenkins MK, Miller SD.
Immunoregulatory pathways in adult responder mice. III. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which afferently regulates DTH responses.
J Mol Cell Immunol. 1985;2(1):1-13.